SCHEMBL4329145

SCHEMBL4329145

COc1cc2[nH]nc(-c3cccc(F)c3)c2cc1C(=O)NCc1ccco1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 7/20 0.48
NTRK1 P04629 1/20 0.48
KDM4E B2RXH2 4/20 0.47
GAA P10253 1/20 0.47
ALDH1A1 P00352 7/20 0.47
HSD17B10 Q99714 4/20 0.46
NPSR1 Q6W5P4 2/20 0.46
TSHR P16473 1/20 0.46
PGK1 P00558 1/20 0.46
SMN1; SMN2 Q16637 4/20 0.45
POLB P06746 2/20 0.45
MAPT P10636 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
MAPK8 P45983 1/20 0.45
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
KMT2A Q03164 3/20 0.44
TLR8 Q9NR97 1/20 0.44
TLR7 Q9NYK1 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4328143 0.88 HPGD (0.53) HPGDKDM4EGAAALDH1A1HSD17B10
SCHEMBL4340981 0.87 HPGD (0.52) HPGDKDM4EGAAALDH1A1HSD17B10
SCHEMBL4340622 0.86 KMT2A (0.52) HPGDKDM4EGAAALDH1A1HSD17B10
SCHEMBL4339183 0.83 HPGD (0.48) HPGDNTRK1KDM4EGAAALDH1A1
SCHEMBL4340974 0.83 NTRK1 (0.49) NTRK1MAPK8TLR8TLR7
SCHEMBL4334956 0.82 HPGD (0.53) HPGDKDM4EGAAALDH1A1HSD17B10
SCHEMBL4329328 0.82 RECQL (0.60) NTRK1KDM4EALDH1A1NPSR1TSHR
SCHEMBL2867928 0.82 HPGD (0.62) HPGDALDH1A1TSHRPOLBMAPT
SCHEMBL4340978 0.80 ALDH1A1 (0.46) HPGDKDM4EGAAALDH1A1HSD17B10
SCHEMBL2864251 0.79 MAP2K4 (0.54) HPGDNTRK1KDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 HPGD 1817/4885NTRK1 1241/4885KDM4E 2531/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 HPGD 1817/4885NTRK1 1241/4885KDM4E 2531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.